Obesity

Latest News

GLP-1 medications and payer benefits | Image credit: zimmytws - stock.adobe.com
Building Accountability Into GLP-1 Benefit Design: Lessons From Delaware and Philadelphia

August 20th 2025

Employers explore glucagon-like peptide-1 (GLP-1) therapies' impact on health benefits, showcasing accountability and data-driven strategies in Philadelphia, Pennsylvania, and Wilmington, Delaware, for sustainable health programs.

GLP-1's  use, in theory should decrease preoperative risks more prevalent amongst those with obesity; however, safety considerations are still necessary. | Image Credit: AdobeStock_Anatta_Tan.jpeg
GLP-1s’ Preoperative Use Requires Safety Considerations

August 15th 2025

AJMC
Trends in Glucagon-Like Peptide 1 Receptor Agonist Prescribing Patterns

August 15th 2025

A new model successfully helped veterans curb loss of control eating behaviors and see a significant reduction in weight loss. | Image Credit: AdobeStock_Yauhen.jpeg
New Model Reduces Binge Eating, Obesity in Veterans

August 7th 2025

A total of 37,111 prenatal and 33,860 postnatal mother-child pairs were included in the study, and there was an association between prenatal air pollutant exposure and obesity in childhood. | Image credit: Victor Moussa - stock.adobe.com
Prenatal Air Pollution Exposure May Influence Childhood Obesity Risk

July 14th 2025

Continuing Medical Education
View All
August 21st 2025

The Role of the Specialty Pharmacist in Optimizing Treatment for Amyotrophic Lateral Sclerosis: The Impact of Early Intervention, Patient-Centered Care, and Disease-Modifying Therapies in Slowing Disease Progression

1.0 Credit / Neurology
August 21st 2025

Advancing Targeted Therapies Aimed at Smoldering Disease in Multiple Sclerosis

1.0 Credit / Immunology, Neurology
August 21st 2025

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology
August 21st 2025

The Impact of Pharmacists and Pharmacy Technicians in Recognizing and Responding to Human Trafficking (Pharmacist Credit)

2.0 Credits / Human Trafficking, Law
August 21st 2025

From Treatment to Prevention: Navigating the Expanding Hereditary Angioedema Treatment Landscape

August 13, 2025 | 1:00 PM & 8:00 PM EDT
August 21st 2025

Innovations in Hidradenitis Suppurativa Treatment: Navigating the Evolving Landscape for Managed Care Professionals

August 19, 2025 | 1:00 PM & 8:00 PM ET
August 21st 2025

Optimizing Outcomes in Myasthenia Gravis: Therapeutic Advances and Value-Based Care Models

August 21, 2025 | 1:00 PM ET & 8:00 PM ET
August 21st 2025

Managed Care Insights on the Advances in the Eosinophilic Esophagitis Treatment Landscape

1.0 Credit / Gastroenterology, Immunology, Rare Diseases
August 21st 2025

An American Journal of Managed Care® Forum: Discussing the Expanding Targeted Therapy Options and Complexities in Metastatic HER2+ Breast Cancer Treatment

1.5 Credits / Breast Cancer, Oncology
August 21st 2025

Managing Patients With COPD: Evidence-Based Care and Optimizing Value of New and Emerging Targeted Therapies

1.0 Credit / Immunology, Pulmonology/Respiratory
August 21st 2025

Managed Care Approaches to Individualize Treatment of Hereditary Angioedema

1.0 Credit / Immunology
August 21st 2025

Prescription Digital Therapeutics in Schizophrenia: A Managed Care Perspective on Advancements

2.0 Credits / Psychiatry
August 21st 2025

Navigating Innovations: A Managed Care Perspective Addressing the Economic Burden of Schizophrenia

3.0 Credits / Psychiatry
August 21st 2025

From Strict Avoidance to Tailored Therapies: Transforming Food Allergy Care

1.5 Credits / Allergy, Immunology
August 21st 2025

The Evolving Strategies for Managing nAMD and DME: Empowering Managed Care Decisions for Improved Patient Outcomes

1.5 Credits / Endocrinology, Diabetes & Metabolism, Ophthalmology/Optometry
August 21st 2025

Managing Schizophrenia: Evidence-Based Care and Optimizing Value of New and Emerging Therapies

1.0 Credit / Psychiatry
August 21st 2025

Closing Gaps in CLL Care: Managed Care Insights and Strategies

1.5 Credit / Hematologic Cancer, Oncology
August 21st 2025

Revolutionizing Acute Pain Relief: Emerging Non-Opioid Therapies and the Essential Role of Pharmacists

1.5 Credit / Pain Management/Opioids
August 21st 2025

Overview and Burden of Migraine

0.5 Credit / Neurology
August 21st 2025

The Role of the Pharmacist Migraine Management

0.5 Credit / Neurology
August 21st 2025

The Evolving Treatment Landscape of Migraine

0.5 Credit / Neurology
August 21st 2025

Evidence-Based Guidelines Point to Leap in Care for Hypertrophic Cardiomyopathy

1.0 Credit / Cardiology
August 21st 2025

ASH Annual Meeting Coverage: Highlighting the Recent Updates in TKI Use in the Treatment of CML – Insights and Application for Managed Care

1.0 Credit / Oncology, Hematology, Hematologic Cancer
August 21st 2025

New and Approved: FDA’s 2024 Drug Lineup

1.5 Credits / General Pharmacy
August 21st 2025

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy
August 21st 2025

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management
August 21st 2025

Leveraging Managed Care to Optimize Patient Outcomes: Integrating Novel Treatments in Schizophrenia

1.5 Credits / Neurology, Psychiatry
August 21st 2025

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health
August 21st 2025

Overcoming Operational and Clinical Barriers in Multiple Myeloma: Managed Care Strategies for Antibody-Based Regimens

1.5 Credits / Hematologic Cancer, Hematology, Oncology
August 21st 2025

Exploring Therapeutic Advances in Myelofibrosis and Key Considerations for Effective Management

1.5 Credits / Oncology, Hematology

More News

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo